AGEN1777

DRUG2 trials

Sponsors

Bristol-Myers Squibb Services Unlimited Company, Bristol-Myers Squibb Services Unlimited Company, Agenus Inc.

Conditions

Advanced CancerNon-small cell lung cancerSolid Tumor

Phase 1

A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors

CompletedNCT05025085

Agenus Inc.Advanced Cancer

Start: 2021-10-04End: 2024-04-01Updated: 2025-10-15

A Phase 1b/2 Study of BMS-986442 in Combination with Nivolumab or Nivolumab and Chemotherapies in Participants with Advanced Solid Tumors and Non-small Cell Lung Cancer

CompletedCTIS2022-503108-26-00

Bristol-Myers Squibb Services Unlimited Company, Bristol-Myers Squibb Services Unlimited CompanyNon-small cell lung cancer, Solid Tumor

Start: 2023-11-06End: 2024-09-04Target: 106Updated: 2024-07-23